The data suggest that this immunosuppression - only approach could benefit patients with DC — and, perhaps, other bone marrow failure syndromes — who are at high risk of poor transplant outcomes because they can not tolerate the toxicity of conventional or even reduced - intensity conditioning. (sciencedaily.com)
He then completed his Internal Medicine residency and Hematology / Oncology fellowship training at Cleveland Clinic, in addition to a research fellowship in bone marrow failure syndromes at the same institution. (vicc.org)
With this new understanding of the enzyme, called Inositol trisphosphate 3 - kinase B (ItpkB), scientists are closer to improving therapies for diseases such as bone marrow failure syndrome, anemia, leukemia, lymphoma and immunodeficiencies. (sciencedaily.com)